Paclitaxel promotes liver graft survival in rats and inhibits hepatocellular carcinoma growth in vitro and is a potentially useful drug for transplant patients with liver cancer

Transplant Proc. 2002 Sep;34(6):2316-7. doi: 10.1016/s0041-1345(02)03251-7.

Authors

I Iesalnieks¹, S Tange, M N Scherer, C Graeb, E Frank, K W Jauch, E K Geissler

Affiliation

¹ Department of Surgery, University of Regensburg, Regensburg, Germany.

PMID: 12270414
DOI: 10.1016/s0041-1345(02)03251-7

No abstract available

MeSH terms

Animals
Antineoplastic Agents, Phytogenic / therapeutic use*
Carcinoma, Hepatocellular / prevention & control*
Cell Line
Graft Survival / drug effects
Graft Survival / physiology*
Humans
Liver Neoplasms / prevention & control*
Liver Transplantation / physiology*
Paclitaxel / therapeutic use*
Postoperative Complications / prevention & control*
Rats
Rats, Inbred ACI
Rats, Inbred BUF
Rats, Inbred Lew
Transplantation, Homologous / physiology

Substances

Antineoplastic Agents, Phytogenic
Paclitaxel